In seeking for the mechanism underlying berberine's beneficial effects on diabetes and insulin-resistance, it has been found that berberine is an agonist of AMP-activated protein kinase (AMPK) [26, 27]. The gene discussed is PRKAA1; the disease is diabetes mellitus.